- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03978806
Prosperando: Fostering Resilience on Dialysis
Fostering Resilience on Dialysis: A Peer Navigator Study to Improve the Well-being of Latinos on Hemodialysis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this project is to assess the feasibility and acceptability of a pilot RCT of a culturally tailored peer-navigator (PN) intervention to improve patient-centered and clinical outcomes for Latino patients with end-stage kidney disease (ESKD). We will compare a culturally tailored intervention that includes a PN to control (standard care). In the culturally tailored intervention, the bilingual PN will provide support with social challenges during 5 visits. We will assess the feasibility of (1) referral, (2) recruitment, (3) retention, (4) intervention implementation, and (5) data collection. We will also assess various outcomes including inter-dialytic weight gain and other adherence and patient-centered outcomes.
Specific Aim 1: Conduct a pilot RCT of the peer navigator intervention to assess feasibility, acceptability, as well as outcomes of the proposed peer navigator intervention.
Hypothesis 1: A culturally tailored intervention that consists of a bilingual/culture-concordant peer navigator that provides support with social challenges and support with adherence using motivational interviewing for Latino end-stage kidney disease (ESKD) patients, is feasible and acceptable.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80220
- Fresenius Medical Care Rocky Mountain Dialysis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-identify as Latino
- Age between 18 and 90 years
- Diagnosed with end-stage kidney disease
- Received standard (thrice-weekly HD) for at least 3 months
- No active substance use (e.g. heavy etoh or opiates)
- Speak English or Spanish as a primary language
- Participants must be able to provide informed consent
Exclusion Criteria:
- Active suicidal intent
- Present or past psychosis or bipolar disorder
- Patient to receive kidney transplantation in the next 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: peer navigator
The first PN visit will take place within 1-2 weeks of consent.
Each of the 5 subsequent PN visits will take place every 1-2 weeks.
We expect patients to complete the intervention within 2-3 months of consent.
The function of the initial visit is to establish trust and ensure a more personal approach with participants.
The community-based PN intervention is grounded in core Latino values (e.g.
trust, personalized relationships).
The core elements of the PN intervention include patient motivational interviewing as well as patient activation, empowerment (e.g.
help with scheduling of healthcare appointments and re-scheduling of missed HD sessions), education (e.g.
education of ESKD and need for renal replacement therapy), and social challenges (e.g.
access to resources for transportation, benefits, immigration issues).
The duration, individuals present during the visit, and content discussed will be documented in the visit form.
|
The intervention is aimed to provide support with social challenges and adherence.
The peer navigator will meet with patients to provide support with social challenges and use motivational interviewing to provide support with adherence.
|
Placebo Comparator: Control Arm (standard of care)
Standard of care
|
Control patients will have met the same inclusion and exclusion criteria as intervention patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Interdialytic weight gain
Time Frame: Data collection 3 months prior to consent (collected retrospectively) and 6 months following study completion
|
Inter-dialytic weight gain will be calculated as the monthly average of the difference between the pre-dialysis weight and the weight at the end of the previous dialysis session, divided by determined dry weight, expressed as a percentage of change in weight per day (%Δkg per day).
|
Data collection 3 months prior to consent (collected retrospectively) and 6 months following study completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kidney Dialysis Quality of Life Short Form - 36 questions
Time Frame: Change from baseline health-related quality of life up to 24 months
|
KDQOL(Kidney Disease Quality Of Life) - Short Form 36 (SF-36).
The KDQOL Short Form-36 (KDQOL-SF-36), a 36 item survey with five subscales (Physical Component Summary, Mental Component Summary, Burden of Kidney Disease subscale, Symptoms and Problems subscale, and Effects of Kidney Disease on Daily Life).
The KDQOL-SF-36 are scored linearly (with higher score indicating better quality of life) on a range of 0-100 using the developer-recommended scoring (available at https://www.rand.org/health-care/surveys_tools/kdqol.html).
|
Change from baseline health-related quality of life up to 24 months
|
Hemodialysis shortening
Time Frame: This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Hemodialysis shortening: Defined as shortening the hemodialysis session by greater than or equal to 10 minutes.
|
This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Hemodialysis adherence
Time Frame: This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Hemodialysis adherence defined defined as the proportion of monthly scheduled sessions missed (other than for vacation or hospitalization)
|
This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Albumin
Time Frame: This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Albumin
|
This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Potassium
Time Frame: This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Potassium
|
This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion.
|
Phosphorus
Time Frame: Assessed 3 months prior to enrollment, monitored monthly during intervention, and followed for 3 months after intervention
|
Phosphorus
|
Assessed 3 months prior to enrollment, monitored monthly during intervention, and followed for 3 months after intervention
|
Social determinants of health composite survey
Time Frame: Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Several questions from various previously validated surveys that assess social determinants of health.
|
Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Self-Efficacy
Time Frame: Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Patient-Reported Outcomes Measurement Information System (PROMIS) measure to assess self-efficacy
|
Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Patient Activation Measure
Time Frame: Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Patient Activation Measure has 13 questions, each item is rated on a four-point scale (1 strong disagree to 4 strong agree, with additional 'non-applicable.'
Level 1 (less than 47) indicates 'not believing activation is important.'
Level 2 (47 to 55.1) indicates 'a lack of knowledge and confidence to take action.'
Level 3 (55.2 to 67) indicates 'beginning to take action.'
Level 4 (greater than 67) indicates 'taking action.'
|
Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Emergency Department visits and hospitalizations
Time Frame: Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Number of Emergency Department (ED) visits and hospitalizations, length of stay
|
Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)
|
Social Isolation
Time Frame: Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
PROMIS measure
|
Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
Qualitative interviews to assess acceptability
Time Frame: Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
10 participants will be interviewed using semi-structured approach.
The results will be a thematic analysis (that ties in the themes and subthemes with illustrative quotes).
|
Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
Kidney transplantation Questions derived/tailored from two previously published questionnaires.
Time Frame: Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
Kidney transplantation interest in pursuing, placement on list, receipt of transplantation.
Questions were derived and tailored from two studies: Ayanian NEJM 1999;341:1661-9 & Bouleware American J of Transplantation 2005;5:1503-1512.
Some are yes/no questions and others are on a Likert Scale.
|
Assessed twice: At time of enrollment and at time of study completion (up to 1 year)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Cukor D, Ver Halen N, Asher DR, Coplan JD, Weedon J, Wyka KE, Saggi SJ, Kimmel PL. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol. 2014 Jan;25(1):196-206. doi: 10.1681/ASN.2012111134. Epub 2013 Oct 10.
- Lora CM, Ricardo AC, Brecklin CS, Fischer MJ, Rosman RT, Carmona E, Lopez A, Balaram M, Nessel L, Tao KK, Xie D, Kusek JW, Go AS, Lash JP. Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials. 2012 Nov;33(6):1238-44. doi: 10.1016/j.cct.2012.07.012. Epub 2012 Jul 27.
- Cervantes L, Jones J, Linas S, Fischer S. Qualitative Interviews Exploring Palliative Care Perspectives of Latinos on Dialysis. Clin J Am Soc Nephrol. 2017 May 8;12(5):788-798. doi: 10.2215/CJN.10260916. Epub 2017 Apr 12.
- Cervantes L, Linas S, Keniston A, Fischer S. Latinos With Chronic Kidney Failure Treated by Dialysis: Understanding Their Palliative Care Perspectives. Am J Kidney Dis. 2016 Feb;67(2):344-7. doi: 10.1053/j.ajkd.2015.09.026. Epub 2015 Nov 20. No abstract available.
- Cervantes L, Chonchol M, Hasnain-Wynia R, Steiner JF, Havranek E, Hull M, Rice J, Kendrick J, Alamillo X, Camacho C, Fischer S. Peer Navigator Intervention for Latinos on Hemodialysis: A Single-Arm Clinical Trial. J Palliat Med. 2019 Jul;22(7):838-843. doi: 10.1089/jpm.2018.0439. Epub 2019 Jan 31.
- Cervantes L, Hull M, Keniston A, Chonchol M, Hasnain-Wynia R, Fischer S. Symptom Burden among Latino Patients with End-Stage Renal Disease and Access to Standard or Emergency-Only Hemodialysis. J Palliat Med. 2018 Sep;21(9):1329-1333. doi: 10.1089/jpm.2017.0663. Epub 2018 May 30.
- Cervantes L, Zoucha J, Jones J, Fischer S. Experiences and Values of Latinos with End Stage Renal Disease: A Systematic Review of Qualitative Studies. Nephrol Nurs J. 2016 Nov-Dec;43(6):479-493.
- Fischer SM, Cervantes L, Fink RM, Kutner JS. Apoyo con Carino: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage. 2015 Apr;49(4):657-65. doi: 10.1016/j.jpainsymman.2014.08.011. Epub 2014 Sep 18.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20-0419
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Racial/Ethnic Minorities on Dialysis
-
University Hospitals Coventry and Warwickshire...UnknownLive Donors, Ethnic Minorities, TransplantationUnited Kingdom
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Family Caregivers | Ethnic MinoritiesBelgium
-
University of California, DavisCompletedHealthy Volunteers From Racial/Ethnic Minority PopulationsUnited States
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living WillBelgium
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Advance Medical Directives | Muslims | Living Will | Turkish OriginBelgium
-
Northwestern UniversityCompletedCharacteristics of Dermatologists Who Focus on Ethnic SkinUnited States
-
University of North Carolina, GreensboroRecruitingBehavioral Symptoms | Depressive Symptoms | Anxiety Disorders and Symptoms | Ethnic-Racial SocializationUnited States
-
Fondazione C.N.R./Regione Toscana "G. Monasterio...CompletedPatients on Dialysis (Hemodialysis, Peritoneal Dialysis)Italy
-
Amsterdam University of Applied SciencesCompletedDiabetes | Overweight | Musculoskeletal Diseases | Sarcopenia | Ethnic MinoritiesNetherlands
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
Clinical Trials on Active Comparator: peer navigator
-
Illinois Institute of TechnologyPatient-Centered Outcomes Research Institute; TrilogyCompletedMental DisordersUnited States
-
University of California, Los AngelesLos Angeles County Department of Public HealthCompletedHIV-infection/AidsUnited States
-
University of California, Los AngelesCompleted
-
Children's National Research InstitutePatient-Centered Outcomes Research InstituteCompletedPremature Birth of Newborn | Newborn Morbidity | Family | Immature Newborn | Infant Newborn DiseaseUnited States
-
Fenway Community HealthHarvard UniversityCompletedPre-Exposure ProphylaxisUnited States
-
Wake Forest University Health SciencesNot yet recruitingHuman Immunodeficiency VirusUnited States
-
Illinois Institute of TechnologyNational Institute on Minority Health and Health Disparities (NIMHD); ACCESS... and other collaboratorsCompletedObesity | Mental DisorderUnited States
-
Rhode Island HospitalBrown UniversityCompletedOpioid-Related Disorders | Opioid Dependence | Opioid Use | Opioid AbuseUnited States
-
Washington State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
University of Illinois at ChicagoPatient-Centered Outcomes Research Institute; American Heart Association; University... and other collaboratorsCompletedMyocardial Infarction | Heart Failure | Pneumonia | Chronic Obstructive Pulmonary Disease | Sickle Cell DiseaseUnited States